Cancer Diagnostics Market 2019 Key highlights, Segmentation, Overview and Forecast

The Research Report on Cancer Diagnostics Market Consist 89 market data tables and 37 figures spread through 197 pages and in-depth TOC, which covers Global Market overview, Major Key Players detailed Analysis, market opportunities, market risk, forecast for the next five years, major driving factors for the market as well as detailed analysis for CAGR, scope, research findings, leading key players marketing strategy to acquire major market in the form of revenue.

The cancer diagnostics market is highly competitive with many big and small players operating in different market segments.

Technological advancements in various fields such as biomarkers, imaging, biopsy, endoscopy; growing number of cancer cases, rapidly rise in geriatric population, awareness initiatives by governments, and increasing government funding are major factors driving the market growth. However, high capital investment and low benefit-cost ratio of biomarkers and dearth of skilled professionals pose restraints to the growth of this market. Improving healthcare infrastructure in emerging countries and growing demand of companion diagnostics offer growth opportunities for this market.

The global cancer diagnostics market is segmented based on technology, application, and region.

Download PDF (cancer diagnostics):

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186559121

The platform-based technology is further segmented into next-generation sequencing, microarrays, PCR, flow cytometry, in situ hybridization, immunohistochemistry, and others. Instrument-based cancer diagnostics is further segmented into imaging systems and biopsy.

Market-by Application

·         Breast Cancer

·         Lung Cancer

·         Colorectal Cancer

·         Melanoma

Cancer Diagnostics Market, by Product

# Platform-based

-          Next-generation Sequencing

-          Microarrays

-          PCR

-          Flow Cytometry

# Instrument-based

-          Imaging Instruments

-          Ultrasound

-          Mammography

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=186559121

Based on region, the market is divided into North America, Europe, Asia, and Rest of the World (RoW). Rest of the World comprises Latin America, Pacific countries, and Middle East and Africa. North America is expected to account for the largest share in the cancer diagnostics market, followed by Europe and Asia. However, the Asian market is slated to grow at the highest CAGR in the coming five years and serves as a revenue pocket for the companies operating in the market.

Some of the major players in the global market include Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Illumina, Inc. (Denmark), Becton, Dickinson and Company (U.S.), GE Healthcare (U.K.), QIAGEN N.V.  (Netherlands), Abbott Laboratories, Inc. (U.S.), Roche Diagnostics (Switzerland), Siemens Healthcare (Germany), Philips Healthcare (U.K.), and C.R. Bard, Inc. (U.S.)

European Healthcare EDI Market 2018 Analysis, Key Players, Size, Growth Rate and Forecast

EDI is increasingly being adopted in the European Healthcare EDI Market; this industry is expected to register significant growth due to greater uptake of EDI solutions among pharmaceuticals and medical device companies owing to various advantages such as reduction in the administration costs, reduced errors, pricing pressure, and lower profit margins. Moreover, the increasing number of government initiatives toward the implementation of IT in the healthcare industry is estimated to propel the demand for healthcare IT solutions, which in turn will drive the healthcare EDI market.

However, high cost of EDI implementation, challenges in management of EDI, security concerns of the data and restricted investments in healthcare EDI by hospitals present challenges to the overall growth of the market. The increasing use of EDI in healthcare manufacturing & distribution industry and gradual acceptance of mobile EDI are the major trends in the EDI market.

In this report, the European Healthcare EDI Market is segmented based on type of transaction, type of purchasing organization, and region. ORDERS was the most preferred transaction type, followed by INVOIC in European healthcare system. In terms of volume, in 2015, approximately 51.2 million purchase orders were generated by hospitals in Germany through EDI. The increasing number of hospitals in Europe adopting EDI solutions especially in supply chain management due reduced errors enabling operational benefits, less errors, faster transaction processing, and various government initiatives are the key factors contributing to the growth of healthcare EDI market in Europe.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=93400242

The European Healthcare EDI Market is growing at a fast pace. Europe is one of the major markets for the use of EDI in healthcare supply chain. Pharmaceutical wholesalers were early adopters of EDI in Europe, and currently process nearly 92%–95% of their orders through EDI. Due to growing competition and decreasing profit margins, pharmaceutical companies and medical device manufacturers in Europe are under increasing pressure to implement EDI systems that help them cut operating costs and remain competitive and profitable. ORDERS, DESADV, and INVOIC are the most preferred EDI transaction types for supply chain management in hospitals across Europe.

EDI primarily focuses on the electronic exchange of business transactions such as purchase orders, shipment authorizations, shipment acknowledgements, advanced shipment notices, or invoices. EDI provides a fast, secure, and easy exchange of information between healthcare organizations. Most of the hospitals in Europe are focusing on deploying a full suite of electronic processes with automated methods to track the complete process of purchase order purchase order acknowledgement, invoice creation/matching, and processing to the accounts payable system.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=93400242

Geographically, the European Healthcare EDI Market is analyzed at the country level, comprising Benelux, Denmark, France, Germany, Italy, Spain, Sweden, Switzerland, and the U.K. Germany, France, Denmark, Sweden are expected to witness a high penetration rate for healthcare EDI in coming years owing to the rising geriatric population, increasing government funding and initiatives, improving healthcare infrastructure, increasing demand for quality healthcare at low costs, and presence of major companies in these regions.

Bayer AG, Pfizer Inc., GlaxoSmithKline PLC, and Abbott Laboratories are the EDI technology leaders in the pharmaceutical and manufacturing sector in Europe.

Medical Robots Transforming Healthcare Market - Growth by Top Key Players and Forecast Analysis

The Research Report analyzes and studies the price variation in medical robots of varied types (surgical/rehabilitation/non-invasive radiosurgery/hospital & pharmacy), selection criteria of adopting medical robots from an end-user perspective, buying a cycle, price wars, and cost-benefits offered by the robots based on existing research studies.

According to the new market research report “Medical Robots Transforming Healthcare: Pricing & Cost-Benefit Assessment (Price Variation (by Product (Surgical Robots, Rehabilitation Robotics, Stereotactic Radiosurgery), by Application, by Geography), Reimbursement, Selection Criteria, Buying Cycle”, published by MarketsandMarkets™

Download PDF - Please share your specific interest to serve you better.@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=66468116

Medical robots are devices that are used to improve the quality of care for patients. The major types of medical robots are surgical robots, hospital and pharmacy robots, rehabilitation robots, and non-invasive radiosurgery robots. Each type of robots varies widely in prices, offer varied benefits & cost-saving advantages, and are subject to different reimbursement structures, buying a cycle, price wars, and other factors.

Browse and in-depth TOC on “Medical Robots Transforming Healthcare Market”
33 — Tables
21 — Figures
97 — Pages

The other factors that influence the robot prices include discounts offered, supply chain mark-ups, reimbursements, and price war. The study elaborates on each of these factors and their association with price variation of different robot types.

The research findings cited in the report encapsulates the buying cycle and the key decision makers for the purchase of a robot. Selection criteria considered by end-user for embracing medical robots is also included in the scope of the study. Additionally, the marketing & promotional strategies focused by the vendors and financing options offered throws light on activities focused by vendors to increase customer access to the highly sophisticated technology.

Marketing and promotion was the dominant strategy adopted by players in the medical robotics market. This strategy was employed by players to increase the awareness of their products and educate potential clientele on the use and benefits of their products.

Request Research Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=66468116

Furthermore, a separate section on cost-benefit assessment covering cost benefit studies and industry opinion is a value-add for the report. The section provides a guideline to the stakeholders in understanding the investment structure and the cost-savings achieved using each type of robot.

Protein Expression Market | Business Overview, Products and Services, Key Insights, Recent Developments

According to the new market research report "Protein Expression Market by Type (E. Coli, Mammalian, Yeast, Pichia, Insect, Baculovirus, Cell-free), Products (Competent Cells, Reagents, Instruments, Services), Application (Therapeutic, Research, Industrial) & End User - Global Forecast to 2022 ", published by MarketsandMarkets™, is expected to reach USD 2,850.5 Million by 2022 from USD 1,654.0 Million in 2017, at a CAGR of 11.5% during the forecast period. 

The prevalence of chronic diseases, increasing research activities on recombinant-based proteins, and growing life sciences & biopharmaceutical industries are the major factors driving the growth of this market.

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=180323924

By systems type, the prokaryotic expression systems segment is expected to dominate the market in 2017

On the basis of systems type, the protein expression market is segmented into prokaryotic expression systems; insect cell expression systems; mammalian cell expression systems; yeast expression systems; cell-free expression systems; and algal-based expression systems.

The prokaryotic expression systems segment has been sub-segmented into Escherichia coli (E. coli) systems and other systems. The E. coli systems segment accounted for the largest share of this market segment. This growth can be attributed to the increasing use of E. coli systems for the production of commercial proteins.

Browse and in-depth TOC on "Protein Expression Market"

127 - Tables

38 - Figures

173 - Pages

By product, the reagents segment is expected to hold the largest share of the market in 2017

The market is segmented into competent cells, expression vectors, instruments, reagents, and services on the basis of products. The reagents segment holds the largest share and also expected to grow at the highest growth rate during the forecast period. This positive growth trend is primarily attributed to increasing research activities and large-scale production of antibodies and vaccines that require kits and reagents.

The therapeutic applications segment is expected to dominate the market in 2017

By application, the market is segmented into therapeutic applications, research applications and industrial applications.The therapeutic applications segment holds the largest share in the market; however, the research applications segment is expected to grow at the highest growth rate during the forecast period. Growth in the research applications segment is primarily attributed to the increase in proteomics-based research activities around the world.

By end user, the pharmaceutical and biotechnology companies segment is expected to hold the largest share of the market in 2017

On the basis of end users, the protein expression market is segmented into academic research institutes; contract research organizations (CROs); pharmaceutical and biotechnology companies; and other end users (food processing industry, detergent manufacturers, paper industry, leather industry, breweries, dairy industry, chemical industry, bioplastic industry, and cosmeceutical industry).The pharmaceutical and biotechnology companies segment holds the largest share in the market; however, the CROs segment is expected to grow at the highest growth rate during the forecast period.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=180323924

Asia offers lucrative growth opportunities

By region, the global market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). While North America holds the largest share of the market in 2016, Asia is expected to grow at the highest CAGR during the forecast period. The presence of emerging economies like China and India; the large population and rising prevalence of chronic diseases in these countries; a growing demand of biologics; and the improving life sciences research infrastructure are the major factors driving the growth of this regional segment.

Key players operating in the protein expression market include Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), Becton, Dickinson & Company (U.S.), Agilent Technologies, Inc. (U.S.), QIAGEN N.V. (Netherlands), Takara Bio Inc. (Japan), Lonza Group Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (U.S.), GenScript Biotech Corporation (China), Lucigen Corporation (U.S.), Synthetic Genomics Inc. (U.S.)

Track and Trace Solutions Market Size, Share, Growth Drivers, Industry Analysis and Application Forecast 2023

The major factors driving the growth of this Track and Trace Solutions Market include the stringent regulations & standards for the implementation of serialization, increasing focus of manufacturers on brand protection, increasing number of packaging-related product recalls, high growth in the generic and OTC markets, and the growing medical device industry.

What the Market Looks Like?

The Global Market Predicted to grow at a CAGR of 14.2% during the forecast period, the Global Track and Trace Solutions Market is estimated to reach USD 4.21 billion by the end of 2024. In 2018, North America held the largest market share, followed by Europe and Asia-Pacific. However, Asia-Pacific is expected to register the fastest growth over the forecast period.

Based on types of software, the market is segmented into plant manager, line controller, enterprise & network manager, bundle tracking, warehouse & shipment manager, case tracking, and pallet tracking software. The plant manager segment accounted for the largest market share in 2018. The rising need to secure the supply chain of pharmaceutical and medical devices manufacturing industries along with strict government legislation are the key factors driving the growth of the plant manager segment.

Download PDF (Please provide your specific interest in this report so as to help you better) @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=158898570

On the basis of technology, the Track and Trace Solutions Market is segmented into linear barcodes, 2D barcodes, and Radio Frequency Identification (RFID). The 2D barcodes segment accounted for the largest market share in 2018. 2D barcodes are preferred for packaging over linear barcodes as they have a higher data storage capacity and contain large amounts of data with fewer variations in image size. This is a major factor driving the market for 2D barcodes.

Based on application, the market is segmented into serialization, aggregation, and tracking, tracing, and reporting solutions. The tracking, tracing, & reporting solutions segment is expected to register the highest CAGR during the forecast period. The high growth of this segment is attributed to the increasing number of regulations such as DSCSA, UDI, and Medical Device Reporting (MDR) for medical devices and pharmaceutical products.

What Drives the Market?

The growth of the global market for Track and Trace Solutions is primarily influenced by the following factors:

·         Stringent Regulations & Standards for the Implementation of Serialization

·         Increasing Focus of Manufacturers on Brand Protection

·         Growth in the Number of Packaging-Related Product Recalls

·         High Growth in the Generic and OTC Markets

·         Growth in the Medical Device Industry

Geographical growth scenario of Track and Trace Solutions Market:

North America accounted for the largest share of the market in 2018, followed by Europe. Factors such as the presence of many pharmaceutical & biotechnology companies and medical device manufacturers, stringent regulations regarding serialization, and the growing medical devices market, are driving the growth of the market in North America.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=158898570

Leading market players and strategies adopted:

The prominent players in the Track and Trace Solutions Market include OPTEL Group (Canada), Mettler-Toledo International Inc. (US), Systech International Inc. (US), TraceLink Inc. (US), Antares Vision (Italy), SAP (US), Xyntek Inc. (US), Adents International (France), SEA Vision Srl (Italy), Robert Bosch (Germany), Körber Medipak Systems AG (Switzerland), Siemens AG (Germany), Uhlmann Group (Germany), Jekson Vision (India), Videojet Technologies, Inc. (US), Zebra Technologies Corporation (US), Axway Inc. (US)

Body Composition Analyzers Market Growth Opportunity and Industry Forecast

Body composition analysis is the process to evaluate the amount of fat, muscle, and bone in the body. It gives the precise measurement of body fat in relation to lean body mass. Evaluation of body composition is essential in order to determine the risks associated with high or low levels of body fat. The growth of the overall Body Composition Analyzers market can be contributed to rise in obese population across the globe, growing health and fitness consciousness among people, increasing government initiatives to encourage physical activity and technological advancements.

According to the new market research report "Body Composition Analyzers Market by Product (Bio-impedance analyzer/DEXA/Skinfold calipers/ADP/Hydrostatic weighing), & End-users (Hospitals/Fitness & wellness centers/Academic & Research Center/Home-users) - Analysis & Global Forecasts", published by MarketsandMarkets™.

Revenue Growth Opportunities:

Body Composition Analyzers Market is projected to reach $668.16 Million, growing at a CAGR of 12.7%, during the forecast period.

Download PDF (Please provide your specific interest in this report so as to help you better): https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=248209133

Market Segmentation in-Detailed:-

The key drivers in the market are growing obese population, growing health and fitness consciousness among people, increasing government initiatives to encourage physical activity and technological advancements.

Based on product, the market is segmented into bio-impedance analyzer, dual energy X-ray absorptiometry (DEXA), skin fold Calipers, air displacement plethysmography (ADP) and hydrostatic weighing. The bio-impedance analyzer is expected to account for the largest share of the market, by product in 2016 and is expected to grow at highest CAGR.  This large share can be attributed to the simplicity, low cost, and better accuracy as compared to other body composition analyzers.

Based on end users, the market is segmented into hospitals, fitness clubs and wellness centers, academic and research centers. In 2016, hospitals segment is estimated to account for the largest share of the body composition analyzer market, by end-users in 2016 and is expected to grow at highest CAGR. The growth of this segment can be attributed to the rise in osteoporosis cases, increasing adoption of body composition analyzers to assess the nutritional status in patients and increasing health consciousness among masses.

Request Research Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=248209133

Worldwide Geographical Segmentation in-detailed:

The Body Composition Analyzers Market is segmented into four regional segments, namely, North America, Europe, the Asia Pacific, and the Rest of the World. North America is expected to account for the largest share of the body composition analyzer market. Its large share can be attributed to rising obesity rates and increasing health clubs and fitness centers in the U.S. However, the Asia-Pacific market is slated to grow at the highest CAGR during the forecast period due to rising trend of overweight and obesity in China, and foothold of local players in Japan.

Leading Key Players in the Worldwide Industry:

The major players operating in the Body Composition Analyzers Market are InBody Co., Ltd (South Korea), Tanita Corporation (Japan), Omron Corporation (Japan), Hologic, Inc. (U.S.) and GE Healthcare (U.S.) among others.

Dental Syringes Market Key Players, Share, Trend, Segmentation, and Forecast

Factors driving the growth of this market include increasing geriatric population, ongoing technological advancements in the field of dental syringes, and supportive government legislations to avoid needlestick injuries. However, the dearth of skilled dental surgeons is expected to limit the optimal growth of this market during the coming years.

According to the new market research report "Dental Syringes Market by Product (Non-disposable Syringes, Disposable Syringes and Safety Syringes), Type (Aspirating & Non-aspirating), Material (Plastic and Metallic), Region (North America, Europe , Asia-Pacific, and RoW) - Forecast", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

Revenue Growth Analysis:

The Global Dental Syringes Market is expected to reach USD 126.9 Million, at a CAGR of 5.2%

Download PDF Brochure (Please provide your specific interest in this report so as to help you better): https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=42523876

In Detailed Market Segmentation:

On the basis of product, the market is categorized into three segments, namely, non-disposable syringes, disposable syringes, and safety syringes. The non-disposable syringes segment is expected to dominate the Dental Syringes Market, mainly due to the growing number of endodontic & periodontic procedures across the globe, significant adoption of non-disposable syringes among dental professionals for administering anesthesia, and greater affordability of these products due to their reusable nature.

Based on type, the market is segmented into two segments, namely, aspirating syringes, and non-aspirating syringes. The aspirating syringes segment is expected to dominate the market during the forecast period. The prominent market position of the aspirating syringes segment can be primarily attributed to the procedural benefits offered by aspirating syringes over conventional syringes (such as easy syringe handling, minimal operational stress, and better operational control), and longer shelf life of metallic syringes (as compared to conventional plastic syringes).

On the basis of material, the market is segmented into metallic and plastic-based dental syringes. Metallic syringes are expected to dominate the Dental Syringes Market during the study period owing to their advantages (such as long shelf life, reusability, and nonreactive nature) and significant adoption of metallic syringes among dentists.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=42523876

Geographical Segmentation and Opportunities:

Emerging markets (such as India, China, Brazil, and Mexico) offer significant growth opportunities for players operating in the dental syringes market. The growth of the market in these regions can be attributed to factors such as rising geriatric population, rising awareness among healthcare professionals related to needlestick injuries, and ongoing government initiatives to modernize & expand healthcare infrastructure.

The market is segmented into four regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World.

The Asia-Pacific market is expected to grow at the highest CAGR during the forecast period. The growth opportunities in the Asia-Pacific region can be attributed to the presence of a large patient population for target diseases (coupled with rapidly growing geriatric population, especially in Japan and China), rising awareness among healthcare professionals related to needlestick injuries, ongoing government initiatives to modernize & expand healthcare infrastructure, and continuous reduction in product prices.

Major Key Players in Worldwide Market:

Septodont (U.S.), 3M Company (U.S.), Dentsply International, Inc. (U.S.), Integra LifeSciences Corporation (U.S.), Vista Dental Products (U.S.), Power Dental USA, Inc. (U.S.), 4tek S.r.l (Italy), A. Titan Instrument Inc. (U.S.), and Delmaks Surgico (Pakistan) were some of the key players operating in the dental syringes market.

Veterinary X-ray Market 2019, Trend, Geographical Segmentation, Forecast

Rising animal health expenditure and growing demand for pet insurance, increasing number of veterinary practitioners in developed regions, and growth in the companion animals’ market are the primary drivers for the veterinary X-ray market during the forecast period.

What the Market Looks Like?

Predicted to grow at a CAGR of 6.4% during the forecast period, the global Veterinary X-ray Market is estimated to reach USD 872 million by the end of 2023.

On the basis of technology, the market is segmented into direct radiography (DR), computed radiography (CR), and film-based radiography systems. The computed radiography systems segment accounted for the largest share of the market in 2017. Benefits offered by CR systems over traditional X-ray systems, resulting in a large-scale replacement of traditional film X-ray systems, is the major factor responsible for the large share of this segment.

Based on the type of animal, the veterinary X-ray market is segmented into small companion animals and large animals. The small companion animals segment accounted for the largest share of the market in 2017. The large share of this segment can be attributed to the growing companion animal population, increasing pet care expenditure, growing demand for pet insurance, and technological advancements in imaging modalities for small companion animals.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=126397675

What Drives the Market?

The growth of the global market for Veterinary X-ray is primarily influenced by the following factors:

·         Growth in Companion Animal Population

·         Rising Demand for Pet Insurance with Growing Animal Health Expenditure

·         Growth in the Number of Veterinary Practitioners and Income Levels in Developed Economies

Geographical growth scenario of Veterinary X-ray Market

North America accounted for the largest share of the market in 2017, followed by Europe and the Asia Pacific. Rising number of veterinary practices, increasing number of companion animals, and rising companion animal healthcare expenditure are some of the key factors driving the growth of the market in North America.

 Leading market players and strategies adopted

The prominent players in the Veterinary X-ray market include IDEXX (US), Fujifilm (Japan), Onex Corporation (Canada), Sedecal (Spain), Agfa-Gevaert (Belgium), Sound Technologies (US), Fujifilm Holdings Corporation (Japan), Canon, Inc (Japan), Examion (Germany), Konica Minolta (US), DRE Veterinary (US), and Heska Corporation (US).

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=126397675

Onex Corporation is the leading player in the market. The company provides imaging systems through its subsidiary Carestream Health. Onex focuses on organic and inorganic growth strategies to strengthen its product portfolio. For instance, in 2015, the company launched the Vita Flex CR X-ray system for companion and livestock animals to cater to the specific needs of the veterinary X-ray market.